COVID-19: Covaxin Gets Restricted Emergency Use Authorisation For “This” Age Group


On Tuesday, April 26, a report by the news agency ANI, claimed that the Drugs Controller General of India (DCGI) has accorded restricted emergency use authorisation to Bharat Biotech’s COVID-19 vaccine, Covaxin for children between the age of 6-12 years.

On the other hand, the agency also reported that the DCGI granted emergency use authorisation to Corbevax as well for children between 5-12 years.

In addition to this, the narrative claims that the body has also granted emergency use authorisation to ZycovD (Zydus Cadila vaccine) for children over the age of 12 years.

(This is a developing story)

Source link


Please enter your comment!
Please enter your name here